12 results on '"Boens S"'
Search Results
2. Phosphatase Regulator NIPP1 Restrains Chemokine-Driven Skin Inflammation.
- Author
-
Verbinnen I, Jonkhout M, Liakath-Ali K, Szekér K, Ferreira M, Boens S, Rouget R, Nikolic M, Schlenner S, Van Eynde A, and Bollen M
- Subjects
- Alopecia genetics, Alopecia pathology, Animals, Cell Adhesion immunology, Cell Proliferation genetics, Chemokines immunology, Dermatitis genetics, Dermatitis pathology, Disease Models, Animal, Epidermis immunology, Hair Follicle immunology, Hair Follicle pathology, Humans, Intracellular Signaling Peptides and Proteins genetics, Keratinocytes immunology, Keratinocytes pathology, Mice, Mice, Knockout, Alopecia immunology, Chemokines metabolism, Dermatitis immunology, Epidermis pathology, Intracellular Signaling Peptides and Proteins metabolism
- Abstract
Nuclear inhibitor of protein phosphatase 1 (NIPP1) is a ubiquitously expressed nuclear protein that regulates functions of protein serine/threonine phosphatase-1 in cell proliferation and lineage specification. The role of NIPP1 in tissue homeostasis is not fully understood. This study shows that the selective deletion of NIPP1 in mouse epidermis resulted in epidermal hyperproliferation, a reduced adherence of basal keratinocytes, and a gradual decrease in the stemness of hair follicle stem cells, culminating in hair loss. This complex phenotype was associated with chronic sterile skin inflammation and could be partially rescued by dexamethasone treatment. NIPP1-deficient keratinocytes massively expressed proinflammatory chemokines and immunomodulatory proteins in a cell-autonomous manner. Chemokines subsequently induced the recruitment and activation of immune cells, in particular conventional dendritic cells and Langerhans cells, accounting for the chronic inflammation phenotype. The data identifies NIPP1 as a key regulator of epidermal homeostasis and as a potential target for the treatment of inflammatory skin diseases., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
3. Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1.
- Author
-
Verbinnen I, Boens S, Ferreira M, Szekér K, Van Wijk L, Van Eynde A, and Bollen M
- Abstract
Nuclear Inhibitor of PP1 (NIPP1) is a conserved regulatory subunit of protein phosphatase PP1. The selective deletion of NIPP1 in mouse liver parenchymal cells or skin epidermal cells culminates in a late-onset hyperproliferation of a subset of resident progenitor cells. Although a hyperplastic phenotype is usually tumor promoting, we show here that the absence of NIPP1 conferred a strong resistance to chemically induced hepatocellular or skin carcinoma. The ablation of NIPP1 did not affect the metabolism of the administered mutagens (diethylnitrosamine or 7,12-dimethylbenz[a]anthracene), but reduced the conversion of mutagen-induced covalent DNA modifications into cancer-initiating mutations. This reduced sensitivity to mutagens correlated with an enhanced DNA-damage response and an augmented expression of rate-limiting DNA-repair proteins (MGMT in liver, XPD and XPG in skin), hinting at an increased DNA-repair capacity. Our data identify NIPP1 as a repressor of DNA repair and as a promising target for novel cancer prevention and treatment therapies.
- Published
- 2020
- Full Text
- View/download PDF
4. Correction: MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
- Author
-
Beke L, Kig C, Linders JTM, Boens S, Boeckx A, van Heerde E, Parade M, De Bondt A, Van den Wyngaert I, Bashir T, Ogata S, Meerpoel L, Van Eynde A, Johnson CN, Beullens M, Brehmer D, and Bollen M
- Published
- 2018
- Full Text
- View/download PDF
5. The protein phosphatase 1 regulator NIPP1 is essential for mammalian spermatogenesis.
- Author
-
Ferreira M, Boens S, Winkler C, Szekér K, Verbinnen I, Van Eynde A, Fardilha M, and Bollen M
- Subjects
- Animals, Biomarkers, Gene Deletion, Germ Cells drug effects, Germ Cells metabolism, Immunohistochemistry, Intracellular Signaling Peptides and Proteins genetics, Male, Mammals, Mice, Mice, Knockout, Mice, Transgenic, Intracellular Signaling Peptides and Proteins metabolism, Protein Phosphatase 1 metabolism, Spermatogenesis drug effects, Spermatogenesis genetics
- Abstract
NIPP1 is one of the major nuclear interactors of protein phosphatase PP1. The deletion of NIPP1 in mice is early embryonic lethal, which has precluded functional studies in adult tissues. Hence, we have generated an inducible NIPP1 knockout model using a tamoxifen-inducible Cre recombinase transgene. The inactivation of the NIPP1 encoding alleles (Ppp1r8) in adult mice occurred very efficiently in testis and resulted in a gradual loss of germ cells, culminating in a Sertoli-cell only phenotype. Before the overt development of this phenotype Ppp1r8
-/- testis showed a decreased proliferation and survival capacity of cells of the spermatogenic lineage. A reduced proliferation was also detected after the tamoxifen-induced removal of NIPP1 from cultured testis slices and isolated germ cells enriched for undifferentiated spermatogonia, hinting at a testis-intrinsic defect. Consistent with the observed phenotype, RNA sequencing identified changes in the transcript levels of cell-cycle and apoptosis regulating genes in NIPP1-depleted testis. We conclude that NIPP1 is essential for mammalian spermatogenesis because it is indispensable for the proliferation and survival of progenitor germ cells, including (un)differentiated spermatogonia.- Published
- 2017
- Full Text
- View/download PDF
6. Brief Report: The Deletion of the Phosphatase Regulator NIPP1 Causes Progenitor Cell Expansion in the Adult Liver.
- Author
-
Boens S, Verbinnen I, Verhulst S, Szekér K, Ferreira M, Gevaert T, Baes M, Roskams T, van Grunsven LA, Van Eynde A, and Bollen M
- Subjects
- Animals, Bile Ducts pathology, Biomarkers metabolism, Cell Proliferation, Hyperplasia, Liver metabolism, Mice, Knockout, Organ Specificity, Stem Cells metabolism, Up-Regulation, Gene Deletion, Intracellular Signaling Peptides and Proteins metabolism, Liver cytology, Stem Cells cytology
- Abstract
The Ppp1r8 gene encodes NIPP1, a nuclear interactor of protein phosphatase PP1. The deletion of NIPP1 is embryonic lethal at the gastrulation stage, which has hampered its functional characterization in adult tissues. Here, we describe the effects of a conditional deletion of NIPP1 in mouse liver epithelial cells. Ppp1r8(-/-) livers developed a ductular reaction, that is, bile-duct hyperplasia with associated fibrosis. The increased proliferation of biliary epithelial cells was at least partially due to an expansion of the progenitor cell compartment that was independent of liver injury. Gene-expression analysis confirmed an upregulation of progenitor cell markers in the liver knockout livers but showed no effect on the expression of liver-injury associated regulators of cholangiocyte differentiation markers. Consistent with an inhibitory effect of NIPP1 on progenitor cell proliferation, Ppp1r8(-/-) livers displayed an increased sensitivity to diet-supplemented 3,5-diethoxycarbonyl-1,4-dihydrocollidine, which also causes bile-duct hyperplasia through progenitor cell expansion. In contrast, the liver knockouts responded normally to injuries (partial hepatectomy, single CCl4 administration) that are restored through proliferation of differentiated parenchymal cells. Our data indicate that NIPP1 does not regulate the proliferation of hepatocytes but is a suppressor of biliary epithelial cell proliferation, including progenitor cells, in the adult liver. Stem Cells 2016;34:2256-2262., (© 2016 AlphaMed Press.)
- Published
- 2016
- Full Text
- View/download PDF
7. The selective inhibition of protein phosphatase-1 results in mitotic catastrophe and impaired tumor growth.
- Author
-
Winkler C, De Munter S, Van Dessel N, Lesage B, Heroes E, Boens S, Beullens M, Van Eynde A, and Bollen M
- Subjects
- Cell Death, Endoribonucleases genetics, HeLa Cells, Humans, Neoplasm Proteins genetics, Neoplasms genetics, Phosphoprotein Phosphatases genetics, Protein Phosphatase 1 genetics, Protein Phosphatase 1 metabolism, RNA-Binding Proteins genetics, Endoribonucleases metabolism, Mitosis, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins metabolism, Neoplasms enzymology, Phosphoprotein Phosphatases metabolism, Protein Phosphatase 1 antagonists & inhibitors, RNA-Binding Proteins metabolism
- Abstract
The serine/threonine protein phosphatase-1 (PP1) complex is a key regulator of the cell cycle. However, the redundancy of PP1 isoforms and the lack of specific inhibitors have hampered studies on the global role of PP1 in cell cycle progression in vertebrates. Here, we show that the overexpression of nuclear inhibitor of PP1 (NIPP1; also known as PPP1R8) in HeLa cells culminated in a prometaphase arrest, associated with severe spindle-formation and chromosome-congression defects. In addition, the spindle assembly checkpoint was activated and checkpoint silencing was hampered. Eventually, most cells either died by apoptosis or formed binucleated cells. The NIPP1-induced mitotic arrest could be explained by the inhibition of PP1 that was titrated away from other mitotic PP1 interactors. Consistent with this notion, the mitotic-arrest phenotype could be rescued by the overexpression of PP1 or the inhibition of the Aurora B kinase, which acts antagonistically to PP1. Finally, we demonstrate that the overexpression of NIPP1 also hampered colony formation and tumor growth in xenograft assays in a PP1-dependent manner. Our data show that the selective inhibition of PP1 can be used to induce cancer cell death through mitotic catastrophe., (© 2015. Published by The Company of Biologists Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
8. MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells.
- Author
-
Beke L, Kig C, Linders JT, Boens S, Boeckx A, van Heerde E, Parade M, De Bondt A, Van den Wyngaert I, Bashir T, Ogata S, Meerpoel L, Van Eynde A, Johnson CN, Beullens M, Brehmer D, and Bollen M
- Subjects
- Apoptosis drug effects, Ataxia Telangiectasia Mutated Proteins biosynthesis, Breast Neoplasms drug therapy, Breast Neoplasms pathology, Breast Neoplasms radiotherapy, Cell Line, Tumor, Cell Proliferation drug effects, Female, Forkhead Box Protein M1, Forkhead Transcription Factors biosynthesis, Gene Expression Regulation, Neoplastic, Humans, MCF-7 Cells, Protein Serine-Threonine Kinases antagonists & inhibitors, Protein Serine-Threonine Kinases genetics, Azepines administration & dosage, Benzamides administration & dosage, Breast Neoplasms genetics, DNA Damage drug effects, Enzyme Inhibitors administration & dosage, Protein Serine-Threonine Kinases biosynthesis
- Abstract
Maternal embryonic leucine zipper kinase (MELK), a serine/threonine protein kinase, has oncogenic properties and is overexpressed in many cancer cells. The oncogenic function of MELK is attributed to its capacity to disable critical cell-cycle checkpoints and reduce replication stress. Most functional studies have relied on the use of siRNA/shRNA-mediated gene silencing. In the present study, we have explored the biological function of MELK using MELK-T1, a novel and selective small-molecule inhibitor. Strikingly, MELK-T1 triggered a rapid and proteasome-dependent degradation of the MELK protein. Treatment of MCF-7 (Michigan Cancer Foundation-7) breast adenocarcinoma cells with MELK-T1 induced the accumulation of stalled replication forks and double-strand breaks that culminated in a replicative senescence phenotype. This phenotype correlated with a rapid and long-lasting ataxia telangiectasia-mutated (ATM) activation and phosphorylation of checkpoint kinase 2 (CHK2). Furthermore, MELK-T1 induced a strong phosphorylation of p53 (cellular tumour antigen p53), a prolonged up-regulation of p21 (cyclin-dependent kinase inhibitor 1) and a down-regulation of FOXM1 (Forkhead Box M1) target genes. Our data indicate that MELK is a key stimulator of proliferation by its ability to increase the threshold for DNA-damage tolerance (DDT). Thus, targeting MELK by the inhibition of both its catalytic activity and its protein stability might sensitize tumours to DNA-damaging agents or radiation therapy by lowering the DNA-damage threshold., (© 2015 Authors.)
- Published
- 2015
- Full Text
- View/download PDF
9. Genome-wide promoter binding profiling of protein phosphatase-1 and its major nuclear targeting subunits.
- Author
-
Verheyen T, Görnemann J, Verbinnen I, Boens S, Beullens M, Van Eynde A, and Bollen M
- Subjects
- Animals, Binding Sites, Cattle, Cell Nucleus enzymology, Cell Nucleus genetics, DNA-Binding Proteins metabolism, Genome, HeLa Cells, Holoenzymes metabolism, Humans, Intracellular Signaling Peptides and Proteins metabolism, Nuclear Proteins metabolism, Protein Subunits metabolism, RNA Polymerase II metabolism, RNA-Binding Proteins metabolism, Rats, Transcription, Genetic, Promoter Regions, Genetic, Protein Phosphatase 1 metabolism
- Abstract
Protein phosphatase-1 (PP1) is a key regulator of transcription and is targeted to promoter regions via associated proteins. However, the chromatin binding sites of PP1 have never been studied in a systematic and genome-wide manner. Methylation-based DamID profiling in HeLa cells has enabled us to map hundreds of promoter binding sites of PP1 and three of its major nuclear interactors, i.e. RepoMan, NIPP1 and PNUTS. Our data reveal that the α, β and γ isoforms of PP1 largely bind to distinct subsets of promoters and can also be differentiated by their promoter binding pattern. PP1β emerged as the major promoter-associated isoform and shows an overlapping binding profile with PNUTS at dozens of active promoters. Surprisingly, most promoter binding sites of PP1 are not shared with RepoMan, NIPP1 or PNUTS, hinting at the existence of additional, largely unidentified chromatin-targeting subunits. We also found that PP1 is not required for the global chromatin targeting of RepoMan, NIPP1 and PNUTS, but alters the promoter binding specificity of NIPP1. Our data disclose an unexpected specificity and complexity in the promoter binding of PP1 isoforms and their chromatin-targeting subunits., (© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2015
- Full Text
- View/download PDF
10. Protein phosphatase PP1-NIPP1 activates mesenchymal genes in HeLa cells.
- Author
-
Van Dessel N, Boens S, Lesage B, Winkler C, Görnemann J, Van Eynde A, and Bollen M
- Subjects
- Binding Sites, Biomarkers metabolism, Cell Proliferation, Cell Transdifferentiation, Endoribonucleases chemistry, Endoribonucleases genetics, HeLa Cells, Humans, Ligands, Mutation, Neoplasm Proteins chemistry, Neoplasm Proteins genetics, Phosphoprotein Phosphatases chemistry, Phosphoprotein Phosphatases genetics, Phosphorylation, Protein Interaction Domains and Motifs, Protein Stability, RNA-Binding Proteins chemistry, RNA-Binding Proteins genetics, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins metabolism, Endoribonucleases metabolism, Epithelial-Mesenchymal Transition, Gene Expression Regulation, Neoplastic, Genes, Neoplasm, Neoplasm Proteins metabolism, Phosphoprotein Phosphatases metabolism, Protein Processing, Post-Translational, RNA-Binding Proteins metabolism, Transcriptional Activation
- Abstract
The deletion of the protein phosphatase-1 (PP1) regulator known as Nuclear Inhibitor of PP1 (NIPP1) is embryonic lethal during gastrulation, hinting at a key role of PP1-NIPP1 in lineage specification. Consistent with this notion we show here that a mild, stable overexpression of NIPP1 in HeLa cells caused a massive induction of genes of the mesenchymal lineage, in particular smooth/cardiac-muscle and matrix markers. This reprogramming was associated with the formation of actin-based stress fibers and retracting filopodia, and a reduced proliferation potential. The NIPP1-induced mesenchymal transition required functional substrate and PP1-binding domains, suggesting that it involves the selective dephosphorylation of substrates of PP1-NIPP1., (Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
11. Interactor-guided dephosphorylation by protein phosphatase-1.
- Author
-
Boens S, Szekér K, Van Eynde A, and Bollen M
- Subjects
- Binding Sites, Catalytic Domain, Enzyme Inhibitors pharmacology, Holoenzymes chemistry, Holoenzymes metabolism, Humans, Phosphorylation, Protein Binding, Substrate Specificity, Drug Design, Enzyme Inhibitors chemistry, Protein Phosphatase 1 metabolism
- Abstract
Protein phosphatase-1 (PP1) is an essential enzyme for every eukaryotic cell and catalyzes more than half of all protein dephosphorylations at serine and threonine residues. The free catalytic subunit of PP1 shows little substrate selectivity but is tightly regulated in vivo by a large variety of structurally unrelated PP1-interacting proteins (PIPs). PIPs form highly specific dimeric or trimeric PP1 holoenzymes by acting as substrates, inhibitors, and/or substrate-specifiers. The surface of PP1 contains many binding sites for short PP1-docking motifs that are combined by PIPs to create a PP1-binding code that is universal, specific, degenerate, nonexclusive, and dynamic. These properties of the PP1-binding code can be used for the rational design of small molecules that disrupt subsets of PP1 holoenzymes and have a therapeutic potential.
- Published
- 2013
- Full Text
- View/download PDF
12. The Arabidopsis thaliana checkpoint kinase WEE1 protects against premature vascular differentiation during replication stress.
- Author
-
Cools T, Iantcheva A, Weimer AK, Boens S, Takahashi N, Maes S, Van den Daele H, Van Isterdael G, Schnittger A, and De Veylder L
- Subjects
- Arabidopsis cytology, Arabidopsis drug effects, Arabidopsis genetics, Bleomycin pharmacology, Cell Death drug effects, Cluster Analysis, DNA Repair drug effects, Enzyme Stability drug effects, Gene Expression Regulation, Plant drug effects, Genes, Plant genetics, Hydroxyurea pharmacology, Kinetics, Meristem cytology, Meristem drug effects, Oligonucleotide Array Sequence Analysis, Phenotype, Plant Vascular Bundle drug effects, S Phase drug effects, Time Factors, Arabidopsis enzymology, Arabidopsis Proteins metabolism, Cell Differentiation drug effects, DNA Replication drug effects, Plant Vascular Bundle cytology, Protein Serine-Threonine Kinases metabolism, Stress, Physiological drug effects
- Abstract
A sessile lifestyle forces plants to respond promptly to factors that affect their genomic integrity. Therefore, plants have developed checkpoint mechanisms to arrest cell cycle progression upon the occurrence of DNA stress, allowing the DNA to be repaired before onset of division. Previously, the WEE1 kinase had been demonstrated to be essential for delaying progression through the cell cycle in the presence of replication-inhibitory drugs, such as hydroxyurea. To understand the severe growth arrest of WEE1-deficient plants treated with hydroxyurea, a transcriptomics analysis was performed, indicating prolonged S-phase duration. A role for WEE1 during S phase was substantiated by its specific accumulation in replicating nuclei that suffered from DNA stress. Besides an extended replication phase, WEE1 knockout plants accumulated dead cells that were associated with premature vascular differentiation. Correspondingly, plants without functional WEE1 ectopically expressed the vascular differentiation marker VND7, and their vascular development was aberrant. We conclude that the growth arrest of WEE1-deficient plants is due to an extended cell cycle duration in combination with a premature onset of vascular cell differentiation. The latter implies that the plant WEE1 kinase acquired an indirect developmental function that is important for meristem maintenance upon replication stress.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.